Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5023,810.851.58%H 23,810.85 · L 23,482.8as of 03 Nov, 3:31 PM IST|Sensex76,917.851.62%H 76,917.85 · L 76,033.74as of 03 Nov, 3:32 PM IST|Bank Nifty55,540.050.98%H 55,739 · L 55,174.1as of 03 Nov, 3:31 PM IST|USD / INR₹94.730.17%H ₹94.89 · L ₹94.6as of 2:21 AM IST|Gold Intl (10g)₹1,20,004.230.74%H ₹1,21,268.17 · L ₹1,18,904.75upd. 3:29 AM IST|Silver Intl (1kg)₹1,51,703.232.12%H ₹1,55,068.66 · L ₹1,48,078.92upd. 3:29 AM IST|Crude WTI₹9,166.070.31%H ₹9,361.22 · L ₹8,865.78upd. 3:29 AM IST|Bitcoin₹73,72,1611.52%H ₹74,28,056.69 · L ₹73,16,265.31upd. 3:35 AM IST|Ethereum₹2,17,1621.79%H ₹2,19,105.04 · L ₹2,15,218.96upd. 3:35 AM IST|Nifty 5023,810.851.58%H 23,810.85 · L 23,482.8as of 03 Nov, 3:31 PM IST|Sensex76,917.851.62%H 76,917.85 · L 76,033.74as of 03 Nov, 3:32 PM IST|Bank Nifty55,540.050.98%H 55,739 · L 55,174.1as of 03 Nov, 3:31 PM IST|USD / INR₹94.730.17%H ₹94.89 · L ₹94.6as of 2:21 AM IST|Gold Intl (10g)₹1,20,004.230.74%H ₹1,21,268.17 · L ₹1,18,904.75upd. 3:29 AM IST|Silver Intl (1kg)₹1,51,703.232.12%H ₹1,55,068.66 · L ₹1,48,078.92upd. 3:29 AM IST|Crude WTI₹9,166.070.31%H ₹9,361.22 · L ₹8,865.78upd. 3:29 AM IST|Bitcoin₹73,72,1611.52%H ₹74,28,056.69 · L ₹73,16,265.31upd. 3:35 AM IST|Ethereum₹2,17,1621.79%H ₹2,19,105.04 · L ₹2,15,218.96upd. 3:35 AM IST|

Public Health

Latest news, explainers and analysis on Public Health. Tracking 8 stories on Arth Vani.

8 stories tracked

Connected in the graph

Latest on Public Health

EPS Urges Tamil Nadu Government to Revive Amma Pharmacies for Affordable Medicines
Breaking
Govt Schemes

EPS Urges Tamil Nadu Government to Revive Amma Pharmacies for Affordable Medicines

Former Tamil Nadu Chief Minister Edappadi K. Palaniswami (EPS) has appealed to the state government to reactivate the Amma pharmacies. The call aims to ensure citizens have continued access to essential medicines at affordable prices, addressing public concerns over healthcare costs.

1d ago·1 min readListen
Roche Calls for Global Healthcare Overhaul to Combat Rising Chronic Disease Costs
real-estate

Roche Calls for Global Healthcare Overhaul to Combat Rising Chronic Disease Costs

Global pharmaceutical company Roche urges a major transformation in worldwide healthcare systems. Jorg Rupp noted current reactive models fail to tackle the growing burden of chronic diseases, leading to heavy financial demands. Roche advocates for governments to view healthcare as a crucial investment to improve health outcomes.

22d ago·2 min readListen
Drug Regulator Seeks Answers on Unapproved Medicines in National Formulary of India
real-estate

Drug Regulator Seeks Answers on Unapproved Medicines in National Formulary of India

India's drug regulator, DCGI, has sought an explanation from the Indian Pharmacopoeia Commission (IPC) regarding the inclusion of several unapproved drugs in the latest edition of the National Formulary of India (NFI 2026). This discrepancy raises concerns about drug safety and official guidance for medical professionals, while stakeholders also note the unavailability of its online version.

24d ago·2 min readListen
Maharashtra FDA Cancels 10 Ayurvedic Drug Licences Over Quality Violations
Breaking
real-estate

Maharashtra FDA Cancels 10 Ayurvedic Drug Licences Over Quality Violations

The Maharashtra Food and Drug Administration (FDA) has cancelled the manufacturing licenses of ten Ayurvedic drug makers following a statewide crackdown. Inspections revealed serious violations of quality control and manufacturing standards, with 135 other manufacturers receiving show-cause notices for non-compliance.

83d ago·1 min readListen
IIT Guwahati Develops 'E-Eye' to Detect Cancer-Causing Toxins in Drinking Water
real-estate

IIT Guwahati Develops 'E-Eye' to Detect Cancer-Causing Toxins in Drinking Water

Researchers at IIT Guwahati have created a portable optical sensing device called 'E-Eye' for instant on-site detection of heavy metals and toxicants in water. The technology supports the Jal Jeevan Mission's goal of providing safe drinking water to every Indian household.

87d ago·1 min readListen
Indian Pharma Alliance Urges Regularisation for Decade-Old Unapproved Drugs
real-estate

Indian Pharma Alliance Urges Regularisation for Decade-Old Unapproved Drugs

The Indian Pharmaceutical Alliance (IPA) is pushing drug authorities to regularise numerous 'legacy drugs' that have been sold in the market for over a decade without central regulatory approval. This move aims to close long-standing regulatory gaps affecting common medicines like sodium valproate and carbamazepine tablets.

90d ago·1 min readListen
Takeda's Qdenga Dengue Vaccine Approved in India, Commercial Launch Expected 2027
real-estate

Takeda's Qdenga Dengue Vaccine Approved in India, Commercial Launch Expected 2027

Takeda Pharmaceutical's new dengue vaccine, Qdenga, has received approval in India. The vaccine is slated for commercial launch in early 2027, initially targeting the private market for individuals before potential government procurement.

90d ago·1 min readListen
National Framework for Bike Ambulances Expected by 2027
Business & Economy

National Framework for Bike Ambulances Expected by 2027

India is set to introduce a new national regulatory framework for bike ambulances, with a rollout expected from 2027. This initiative aims to standardize critical aspects like construction, safety, and patient handling, which are currently unregulated.

91d ago·2 min readListen
real-estate products
Compare & act on the right product for this topic
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
12.9%
3Y CAGR
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
12.2%
3Y CAGR
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
12.1%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
10.8%
3Y CAGR
ICICI Prudential Balanced Advantage Fund
ICICI Prudential Mutual Fund · Hybrid
10.7%
3Y CAGR
HDFC Balanced Advantage Fund
HDFC Mutual Fund · Hybrid
10.7%
3Y CAGR

Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.

Explore all entities in the Knowledge Graph